Drug
Heparin, Low-Molecular-Weight
Heparin, Low-Molecular-Weight is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Phase Distribution
Ph phase_1
2
40%
Ph phase_2
1
20%
Ph not_applicable
1
20%
Ph phase_3
1
20%
Phase Distribution
2
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(4)
Other(1)
Detailed Status
Completed4
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 12 (40.0%)
Phase 21 (20.0%)
Phase 31 (20.0%)
N/A1 (20.0%)
Trials by Status
completed480%
unknown120%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_1
Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Subcutaneous Single Dose
NCT01692158
completedphase_1
Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Intravenous Administration
NCT01692171
completedphase_2
Role of Heparin in Poor Responders Undergoing In Vitro Fertilisation
NCT01315093
completednot_applicable
Effects of Exercise in Combination With Epoetin Alfa
NCT00577096
unknownphase_3
ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER.
NCT01589146
Clinical Trials (5)
Showing 5 of 5 trials
NCT01692158Phase 1
Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Subcutaneous Single Dose
NCT01692171Phase 1
Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Intravenous Administration
NCT01315093Phase 2
Role of Heparin in Poor Responders Undergoing In Vitro Fertilisation
NCT00577096Not Applicable
Effects of Exercise in Combination With Epoetin Alfa
NCT01589146Phase 3
ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER.
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5